FIELD: biotechnology.
SUBSTANCE: nucleotide sequence encoding a recombinant protein - interferon beta analog, optimized for expression in E. coli cells. E. coli BL-30-B cell, intended for interferon beta recombinant protein production is obtained by transformation of E. coli BL (DE3) cells by rET30a plasmid containing the said nucleic acid. E. coli BL-32-B cell, intended for interferon beta recombinant protein production is obtained by transformation of E. coli BL (DE3) cells by rET32a plasmid containing the said nucleic acid.
EFFECT: invention provides a recombinant protein.
3 cl, 5 dwg, 9 tbl, 9 ex
Authors
Dates
2017-03-24—Published
2015-06-19—Filed